Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 08/31/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Seqirus Inc.
*MAILING ADDRESS
475 Green Oaks Parkway
*CITY
Holly Springs
*STATE
(Required for U.S. applicants)
North Carolina
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
27540
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
vaccines; vaccines for human use; flu vaccines
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
042
*IDENTIFICATION
conducting clinical trials for pharmaceutical preparations; conducting clinical trials for flu vaccines; providing information about the
results of clinical trials for flu vaccines; providing medical and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and
development
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
044
*IDENTIFICATION
pharmaceutical and medical information
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Nancy Sabarra
ATTORNEY DOCKET NUMBER
SEQS 2110453
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Fross Zelnick Lehrman & Zissu, P.C.
STREET
151 West 42nd St., 17th Fl.
CITY
New York
STATE
New York
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
10036
PHONE
212-813-5900
EMAIL ADDRESS
Sabarra-Docket@fzlz.com
OTHER APPOINTED ATTORNEY
All other attorneys in the firm
CORRESPONDENCE INFORMATION
NAME
Nancy Sabarra
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
Sabarra-Docket@fzlz.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
3
APPLICATION FOR REGISTRATION PER CLASS
350
*TOTAL FEES DUE
1050
*TOTAL FEES PAID
1050
SIGNATURE INFORMATION
SIGNATURE
NOT PROVIDED
SIGNATORY'S NAME
NOT PROVIDED
SIGNATORY'S POSITION
NOT PROVIDED
DATE SIGNED
NOT PROVIDED
PTO- 1478
Approved for use through 08/31/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:90894560
Filing Date:08/20/2021
To the Commissioner for Trademarks:
MARK: ALLY (Standard Characters, see mark)
The literal element of the mark consists of ALLY. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Seqirus Inc., a corporation of Delaware, having an address of
475 Green Oaks Parkway
Holly Springs, North Carolina 27540
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: vaccines; vaccines for human use; flu vaccines
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 042: conducting clinical trials for pharmaceutical preparations; conducting clinical trials for flu vaccines; providing information about the results of clinical trials for
flu vaccines; providing medical and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 044: pharmaceutical and medical information
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Nancy Sabarra. Other appointed attorneys are All other attorneys in the firm. Nancy Sabarra of Fross Zelnick Lehrman & Zissu, P.C., is a
member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
151 West 42nd St., 17th Fl.
New York, New York 10036
United States
212-813-5900(phone)
Sabarra-Docket@fzlz.com
The docket/reference number is SEQS 2110453.
Nancy Sabarra submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Nancy Sabarra
PRIMARY EMAIL FOR CORRESPONDENCE: Sabarra-Docket@fzlz.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1050 has been submitted with the application, representing payment for 3 class(es).
Declaration
Declaration Signature
Signature: Not Provided Date: Not Provided
Signatory's Name: Not Provided
Signatory's Position: Not Provided
Signatory's Phone Number: Not Provided
Payment Sale Number: 90894560
Payment Accounting Date: 08/20/2021
Serial Number: 90894560
Internet Transmission Date: Fri Aug 20 18:52:33 ET 2021
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XX-2021082018523378
9960-90894560-7811527251b574943d276b8a51
ec413dc6469f55ec813252bf0a89742bbb9fbd3-
DA-52334444-20210820185110441922